Bruno P. Imbimbo

Citace

	Všechny	Od 2020
Citace	15750	6338
h-index	70	35
i10-index	196	106

1300

650

325

975

1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202551 64 118 62 103 126 191 299 223 186 174 138 131 125 99 132 119 144 155 322 492 593 654 716 661 673 715 759 851 1102 1203 1273 1280 1249 220

Veřejný přístup

Zobrazit všechny

28 článků

9 článků

dostupné

nedostupné

Vychází ze zplnomocnění pro financování

Spoluautoři

Francesco PanzaNeurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense OrgansE-mailová adresa ověřena na: uniba.it
vincenzo solfrizziuniversity of bariE-mailová adresa ověřena na: uniba.it
Davide SeripaBiologo Dirigente di Ricerca, U.O.C. Geriatria, I.R.C.C.S. "Casa Sollievo della Sofferenza".E-mailová adresa ověřena na: operapadrepio.it
Giancarlo LogroscinoFull Professor of Neurology, University of Bari. Director of the Center for NeurodegenerativeE-mailová adresa ověřena na: uniba.it
Antonio GrecoAssociate professor of otorhinolaryngology, Sapienza University of RomeE-mailová adresa ověřena na: uniroma1.it
Antonio Danieleassistant professor, Catholic University, Rome, ItalyE-mailová adresa ověřena na: unicatt.it
Gabrio BassottiClinica di Gastroenterologia ed Epatologia, Dipartimento di Medicina, Università di PerugiaE-mailová adresa ověřena na: unipg.it
Nunzio PomaraProfessor of Psychiatry and Pathology NYU Langone Medical CenterE-mailová adresa ověřena na: nki.rfmh.org
Marina PizziFull Professor of Pharmacology University of BresciaE-mailová adresa ověřena na: unibs.it
Rodolfo SardoneHead of Urban Health Center, Local Healthcare Authority of TarantoE-mailová adresa ověřena na: asl.taranto.it
Emanuele SCAFATOEpidemiologo, Gastroenterologo, Direttore Osserv. Naz. Alcol e Centro OMS ricerca alcolE-mailová adresa ověřena na: iss.it
marzia baldereschimedico ricercatore Consiglio Nazionale delle RicercheE-mailová adresa ověřena na: in.cnr.it
Domenico InzitariDept. Neurofarba, Florence University, ItalyE-mailová adresa ověřena na: unifi.it
Lucia GalluzzoSenior Researcher, Istituto Superiore di SanitàE-mailová adresa ověřena na: iss.it
Antonio Di CarloInstitute of Neurosciences, Italian National Research CouncilE-mailová adresa ověřena na: in.cnr.it
Daniele SancarloResearcher. IRCCS Casa Sollievo delle Sofferenza. San Giovanni Rotondo. Italy.E-mailová adresa ověřena na: operapadrepio.it
Gianluigi GiannelliDirettore Scientifico IRCCS "Saverio de Bellis"E-mailová adresa ověřena na: irccsdebellis.it
Vittorio DibelloDepartment of Orofacial Pain and Dysfunction, Academic Centre of Dentistry Amsterdam (ACTA)E-mailová adresa ověřena na: acta.nl
Vito GUERRAIRCCS De Bellis - Castellana Grotte - ItalyE-mailová adresa ověřena na: irccsdebellis.it
Andrea GiustinaUniversità Vita Salute San Raffaele, MilanoE-mailová adresa ověřena na: hsr.it

Sledovat

Bruno P. Imbimbo

Chiesi Farmaceutici

E-mailová adresa ověřena na: chiesi.com

Alzheimer


Název Seřadit podle citací Seřadit podle roku Seřadit podle názvu	Citace Citace	Rok
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease F Panza, M Lozupone, G Logroscino, BP Imbimbo Nature Reviews Neurology 15 (2), 73-88, 2019	970	2019
Late-life depression, mild cognitive impairment, and dementia: possible continuum? F Panza, V Frisardi, C Capurso, A D'Introno, AM Colacicco, BP Imbimbo, ... The American Journal of Geriatric Psychiatry 18 (2), 98-116, 2010	832	2010
The β-secretase BACE1 in Alzheimer’s disease H Hampel, R Vassar, B De Strooper, J Hardy, M Willem, N Singh, J Zhou, ... Biological psychiatry 89 (8), 745-756, 2021	594	2021
Diet and Alzheimer’s disease risk factors or prevention: the current evidence V Solfrizzi, F Panza, V Frisardi, D Seripa, G Logroscino, BP Imbimbo, ... Expert review of neurotherapeutics 11 (5), 677-708, 2011	420	2011
Relationships of dietary patterns, foods, and micro-and macronutrients with Alzheimer’s disease and late-life cognitive disorders: a systematic review V Solfrizzi, C Custodero, M Lozupone, BP Imbimbo, V Valiani, P Agosti, ... Journal of Alzheimer’s Disease 59 (3), 815-849, 2017	377	2017
Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment? BP Imbimbo, V Solfrizzi, F Panza Frontiers in aging neuroscience 2, 1517, 2010	340	2010
A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's disease H Hampel, F Caraci, AC Cuello, G Caruso, R Nisticò, M Corbo, F Baldacci, ... Frontiers in immunology 11, 456, 2020	286	2020
Colonic mass movements in idiopathic chronic constipation. G Bassotti, M Gaburri, BP Imbimbo, L Rossi, F Farroni, MA Pelli, A Morelli Gut 29 (9), 1173-1179, 1988	276	1988
γ-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes B P Imbimbo, G AM Giardina Current topics in medicinal chemistry 11 (12), 1555-1570, 2011	263	2011
Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms V Frisardi, F Panza, D Seripa, BP Imbimbo, G Vendemiale, A Pilotto, ... Journal of Alzheimer’s Disease 22 (3), 715-740, 2010	230	2010
Tau‐Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease F Panza, V Solfrizzi, D Seripa, BP Imbimbo, M Lozupone, A Santamato, ... BioMed research international 2016 (1), 3245935, 2016	215	2016
Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man E Ghigo, E Arvat, L Gianotti, BP Imbimbo, V Lenaerts, R Deghenghi, ... The Journal of Clinical Endocrinology & Metabolism 78 (3), 693-698, 1994	214	1994
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms F Panza, V Frisardi, C Capurso, BP Imbimbo, G Vendemiale, A Santamato, ... Journal of Alzheimer's disease 21 (3), 691-724, 2010	205	2010
Amyloid‐β immunotherapy for alzheimer disease: Is it now a long shot? F Panza, M Lozupone, D Seripa, BP Imbimbo Annals of neurology 85 (3), 303-315, 2019	201	2019
Therapeutic potential of γ-secretase inhibitors and modulators BP Imbimbo Current topics in medicinal chemistry 8 (1), 54-61, 2008	193	2008
Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease BP Imbimbo, S Ottonello, V Frisardi, V Solfrizzi, A Greco, D Seripa, ... Expert review of clinical immunology 8 (2), 135-149, 2012	179	2012
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? F Panza, V Frisardi, D Seripa, G Logroscino, A Santamato, BP Imbimbo, ... International journal of geriatric psychiatry 27 (12), 1218-1238, 2012	173	2012
Reversible cognitive frailty, dementia, and all-cause mortality. The Italian longitudinal study on aging V Solfrizzi, E Scafato, D Seripa, M Lozupone, BP Imbimbo, A D'Amato, ... Journal of the American Medical Directors Association 18 (1), 89. e1-89. e8, 2017	172	2017
Synthesis and Biological Activity of Flurbiprofen Analogues as Selective Inhibitors of β-Amyloid₁_-₄₂ Secretion I Peretto, S Radaelli, C Parini, M Zandi, LF Raveglia, G Dondio, ... Journal of Medicinal Chemistry 48 (18), 5705-5720, 2005	172	2005
Time to test antibacterial therapy in Alzheimer’s disease F Panza, M Lozupone, V Solfrizzi, M Watling, BP Imbimbo Brain 142 (10), 2905-2929, 2019	169	2019

Systém momentálně nemůže danou operaci provést. Zkuste to znovu později.

Články 1–20

Citace za rok

Duplicitní citace

Sloučené citace

Přidat spoluautorySpoluautoři

Sledovat

Citace

Spoluautoři